U.S. Pharmacist Vaccine Update
August 2019

Vaccine Reduces Shingles in
Post–Stem-Cell Transplant Patients

Stem-cell transplants are increasingly being used to treat several blood cancers, such as leukemia, multiple myeloma, and lymphoma. One of the greatest barriers, however, is the high rate of shingles development after the procedure, according to a recent study. Researchers determined, however, that the recombinant zoster vaccine could prevent the painful rash in those cancer patients. Here are more details.


No Toddler Health Issues
From Influenza Vaccination
During Pregnancy

Pregnant women and their newborn infants are at especially high risk for influenza, leading to the United States and other countries recommending vaccination for expectant mothers. Immunization rates remain low, however, at least partly because of concerns about longer term health risks in offspring. A new study found no evidence of increased problems up to age 5 years in those children exposed in utero to the 2009 H1N1 “swine flu” vaccine, however. Read more.

Missed Opportunities Keep Pneumococcal Vaccination
Rates Lower

Pneumonia is especially dangerous for adults aged 65 years and for older and younger people with certain risk factors. Yet vaccination rates are falling far short of public-health goals, at least partly because of missed opportunities, according to a new study. Find out how many healthcare visits unimmunized patients had in which they didn’t receive a pneumonia vaccine, as well as the setting where opportunities were most likely to be missed.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App